JP2025508835A5 - - Google Patents
Info
- Publication number
- JP2025508835A5 JP2025508835A5 JP2024550197A JP2024550197A JP2025508835A5 JP 2025508835 A5 JP2025508835 A5 JP 2025508835A5 JP 2024550197 A JP2024550197 A JP 2024550197A JP 2024550197 A JP2024550197 A JP 2024550197A JP 2025508835 A5 JP2025508835 A5 JP 2025508835A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- binding protein
- composition according
- bispecific binding
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263313483P | 2022-02-24 | 2022-02-24 | |
| US63/313,483 | 2022-02-24 | ||
| PCT/CN2023/077870 WO2023160610A1 (en) | 2022-02-24 | 2023-02-23 | Bispecific binding proteins against alarmins and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025508835A JP2025508835A (ja) | 2025-04-10 |
| JP2025508835A5 true JP2025508835A5 (https=) | 2026-02-27 |
Family
ID=87764833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024550197A Pending JP2025508835A (ja) | 2022-02-24 | 2023-02-23 | アラーミンに対する二重特異性結合タンパク質およびその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240409647A1 (https=) |
| EP (1) | EP4482525A1 (https=) |
| JP (1) | JP2025508835A (https=) |
| KR (1) | KR20240161653A (https=) |
| CN (1) | CN119183384A (https=) |
| AU (1) | AU2023223413A1 (https=) |
| CA (1) | CA3253236A1 (https=) |
| CL (1) | CL2024002512A1 (https=) |
| IL (1) | IL315208A (https=) |
| MX (1) | MX2024010459A (https=) |
| WO (1) | WO2023160610A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025118126A1 (zh) * | 2023-12-05 | 2025-06-12 | 中国抗体制药有限公司 | 抗il-17rb抗体、或其抗原结合片段或组合物的用途 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4634665A (en) | 1980-02-25 | 1987-01-06 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US5179017A (en) | 1980-02-25 | 1993-01-12 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4475196A (en) | 1981-03-06 | 1984-10-02 | Zor Clair G | Instrument for locating faults in aircraft passenger reading light and attendant call control system |
| US4447233A (en) | 1981-04-10 | 1984-05-08 | Parker-Hannifin Corporation | Medication infusion pump |
| US4439196A (en) | 1982-03-18 | 1984-03-27 | Merck & Co., Inc. | Osmotic drug delivery system |
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US4447224A (en) | 1982-09-20 | 1984-05-08 | Infusaid Corporation | Variable flow implantable infusion apparatus |
| US4510245A (en) | 1982-11-18 | 1985-04-09 | Chiron Corporation | Adenovirus promoter system |
| US4487603A (en) | 1982-11-26 | 1984-12-11 | Cordis Corporation | Implantable microinfusion pump system |
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4486194A (en) | 1983-06-08 | 1984-12-04 | James Ferrara | Therapeutic device for administering medicaments through the skin |
| US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
| US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
| US5374548A (en) | 1986-05-02 | 1994-12-20 | Genentech, Inc. | Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor |
| MX9203291A (es) | 1985-06-26 | 1992-08-01 | Liposome Co Inc | Metodo para acoplamiento de liposomas. |
| US4968615A (en) | 1985-12-18 | 1990-11-06 | Ciba-Geigy Corporation | Deoxyribonucleic acid segment from a virus |
| AU582288B2 (en) | 1986-03-07 | 1989-03-16 | Damon Biotech Inc. | Vector and method for achieving high level expression in eukaryotic cells |
| US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
| US4941880A (en) | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
| US5108921A (en) | 1989-04-03 | 1992-04-28 | Purdue Research Foundation | Method for enhanced transmembrane transport of exogenous molecules |
| US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
| US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
| US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
| US9090694B2 (en) * | 2012-04-30 | 2015-07-28 | Janssen Biotech, Inc. | ST2L antibody antagonists |
| US9840557B2 (en) * | 2014-09-23 | 2017-12-12 | Regeneron Pharmaceuticals, Inc. | Anti-IL-25 antibodies and uses thereof |
| MX2018013038A (es) * | 2016-04-27 | 2019-03-28 | Pfizer | Anticuerpos anti-il-33, composiciones, metodos y usos de los mismos. |
| GB201820006D0 (en) | 2018-12-07 | 2019-01-23 | Lifearc | Humanised anti-IL17BR antibody |
| PE20230252A1 (es) * | 2020-03-13 | 2023-02-07 | Genentech Inc | Anticuerpos anti-interleucina-33 y sus usos de estos |
| GB202018015D0 (en) * | 2020-11-16 | 2020-12-30 | Res & Innovation Uk | Composition and methods for the treatment of intestinal cancer |
-
2023
- 2023-02-23 AU AU2023223413A patent/AU2023223413A1/en active Pending
- 2023-02-23 CA CA3253236A patent/CA3253236A1/en active Pending
- 2023-02-23 JP JP2024550197A patent/JP2025508835A/ja active Pending
- 2023-02-23 IL IL315208A patent/IL315208A/en unknown
- 2023-02-23 KR KR1020247031303A patent/KR20240161653A/ko active Pending
- 2023-02-23 WO PCT/CN2023/077870 patent/WO2023160610A1/en not_active Ceased
- 2023-02-23 EP EP23759234.0A patent/EP4482525A1/en active Pending
- 2023-02-23 CN CN202380035878.6A patent/CN119183384A/zh active Pending
-
2024
- 2024-08-22 CL CL2024002512A patent/CL2024002512A1/es unknown
- 2024-08-23 US US18/814,167 patent/US20240409647A1/en active Pending
- 2024-08-26 MX MX2024010459A patent/MX2024010459A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020520665A5 (https=) | ||
| RU2019121086A (ru) | Иммунотерапия с применением антител, связывающих лиганд 1 белка программируемой смерти клеток (PD-L1) | |
| WO2022105914A1 (zh) | Cd70抗体及其应用 | |
| JP2019516392A5 (https=) | ||
| JP2024540148A5 (https=) | ||
| JP2023509390A5 (https=) | ||
| AU2022332499A1 (en) | Fap/cd40 binding molecule and medicinal use thereof | |
| WO2019195313A1 (en) | Anti-vegf antagonist and pedf agonist constructs and uses thereof | |
| US20250346673A1 (en) | Anti-bdca2 antibody and use thereof | |
| CN112074540B (zh) | 细胞接合的结合分子 | |
| JP7717687B2 (ja) | 腎疾患における抗幹細胞因子抗体及びその使用方法 | |
| JP2024516098A5 (https=) | ||
| RU2018129180A (ru) | Тромбиновое антитело, антиген-связывающий фрагмент и их фармацевтическое применение | |
| JP2025505650A5 (https=) | ||
| JP2025508835A5 (https=) | ||
| JP2024523514A5 (https=) | ||
| US20260042865A1 (en) | Multispecific molecules for clearance of immunoglobulins in the treatment of autoantibody-induced diseases | |
| TW202415677A (zh) | 抗TNFα抗體及組合物 | |
| JP2020533953A5 (https=) | ||
| WO2024088342A1 (en) | Antibodies against cd24 and uses thereof | |
| RU2844744C1 (ru) | Антитела против фактора стволовых клеток и способы их применения | |
| TH2101003389A (th) | แอนติ-il-17a แอนติบอดี และการใช้งานของพวกมัน | |
| CN121399160A (zh) | 靶向ccr2的抗体 | |
| JP2025504543A (ja) | Ｂｔｌａに対する抗体及びその使用 | |
| JP2025533189A (ja) | 上皮増殖因子受容体バリアントｉｉｉ抗体 |